Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1989-12-18
1992-02-18
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424448, 424485, 424486, 424487, 4241961, 514783, 514879, A61F 1302, A61L 1544, A61K 970, A61K 3140
Patent
active
050892673
ABSTRACT:
The present invention relates to a transdermal therapeutical system for the administration of physostigmine to the skin via a cover layer which is impermeable to active substances, a pressure-sensitive adhesive reservoir layer, and optionally a removable protective layer, said reservoir layer consisting of 10-90% polymeric material selected from the groups consisting of block copolymers on the basis of styrene and 1,3-dienes, polyisobutylenes, polymers on the basis of acrylates and/or methacrylates and esters of hydrogenated colophonium, 0-30%-wt softeners on the basis of hydrocarbons and/or esters, and 0.1-20%-wt physostigmine.
REFERENCES:
patent: 3996934 (1976-12-01), Zaffaroni
patent: 4668506 (1987-05-01), Bawa
patent: 4765985 (1988-08-01), Leeson
patent: 4788063 (1988-11-01), Fisher et al.
patent: 4911707 (1990-03-01), Heiber et al.
Grant & Hackh's Chemical Dictionary, 5th Ed., pp. 146, 510.
The Merck Index, S. Budavari Ed., Merck & Co; Rahway, N.J., 1989, p. 1172.
Hille Thomas
Hoffmann Hans-Rainer
Huber Hans-Joachim
Koch Axel
Schneider Gerhard
Klinge Pharma GmbH
LTS Lohmann Therapie-Systeme GmbH & Co. KG
Page Thurman K.
Webman Edward J.
LandOfFree
Transdermal therapeutical system comprising physostigmine as act does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal therapeutical system comprising physostigmine as act, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal therapeutical system comprising physostigmine as act will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1821794